Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Goldberg

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Pediatric Research|May 31, 2022
Characteristics of patients diagnosed as non-allergic following food allergy oral immunotherapy referralYael Koren, Liat Nachshon, Michael R Goldberg, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 19, 2015
Patient quality of life following induction of oral immunotherapy for food allergyNa'ama Epstein Rigbi, Yitzhak Katz, Michael R Goldberg, et al.
Eclinicalmedicine|March 15, 2021
Characteristics and associated morbidities of young adults with misconceived food allergy: A cross-sectional studyLiat Nachshon, Naama Schwartz, Michael R Goldberg, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 21, 2018
Reply to "On the reliability of the CD123-endowed basophil activation test (BAT) and its application in food allergy"Michael Y Appel, Liat Nachshon, Arnon Elizur, et al.
Pharmacotherapy|July 27, 2010
Single-dose pharmacokinetics and tolerability of telavancin in elderly men and womenMichael R Goldberg, Shekman L Wong, Jeng-Pyng Shaw, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|October 14, 2024
Oral immunotherapy improves the quality of life of adults with food allergyNa'ama Epstein-Rigbi, Michael B Levy, Liat Nachshon, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 11, 2020
Subjective oral symptoms are insufficient predictors of a positive oral food challengeLiat Nachshon, Oren Zipper, Michael B Levy, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 16, 2021
Medical clown support is associated with better quality of life of children with food allergy starting oral immunotherapyNaama Epstein Rigbi, Naama Schwartz, Michael R Goldberg, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 24, 2018
Food allergy to previously tolerated foods: Course and patient characteristicsLiat Nachshon, Michael R Goldberg, Arnon Elizur, et al.
Pharmacotherapy|December 25, 2009
Lack of effect of moderate hepatic impairment on the pharmacokinetics of telavancinMichael R Goldberg, Shekman L Wong, Jeng-Pyng Shaw, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Pediatric Research|May 31, 2022
Characteristics of patients diagnosed as non-allergic following food allergy oral immunotherapy referralYael Koren, Liat Nachshon, Michael R Goldberg, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 19, 2015
Patient quality of life following induction of oral immunotherapy for food allergyNa'ama Epstein Rigbi, Yitzhak Katz, Michael R Goldberg, et al.
Eclinicalmedicine|March 15, 2021
Characteristics and associated morbidities of young adults with misconceived food allergy: A cross-sectional studyLiat Nachshon, Naama Schwartz, Michael R Goldberg, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 21, 2018
Reply to "On the reliability of the CD123-endowed basophil activation test (BAT) and its application in food allergy"Michael Y Appel, Liat Nachshon, Arnon Elizur, et al.
Pharmacotherapy|July 27, 2010
Single-dose pharmacokinetics and tolerability of telavancin in elderly men and womenMichael R Goldberg, Shekman L Wong, Jeng-Pyng Shaw, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|October 14, 2024
Oral immunotherapy improves the quality of life of adults with food allergyNa'ama Epstein-Rigbi, Michael B Levy, Liat Nachshon, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 11, 2020
Subjective oral symptoms are insufficient predictors of a positive oral food challengeLiat Nachshon, Oren Zipper, Michael B Levy, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 16, 2021
Medical clown support is associated with better quality of life of children with food allergy starting oral immunotherapyNaama Epstein Rigbi, Naama Schwartz, Michael R Goldberg, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 24, 2018
Food allergy to previously tolerated foods: Course and patient characteristicsLiat Nachshon, Michael R Goldberg, Arnon Elizur, et al.
Pharmacotherapy|December 25, 2009
Lack of effect of moderate hepatic impairment on the pharmacokinetics of telavancinMichael R Goldberg, Shekman L Wong, Jeng-Pyng Shaw, et al.
Pageof 9